Presentation of RENUTEND

RENUTEND is a new treatment indicated to improve the healing of tendon and suspensory ligament injuries in horses.
As an active principle, it contains mesenchymal stem cells derived from equine peripheral blood, programmed to be tenogenic. The product aims to promote tissue restoration and healing mechanisms in tendons and ligaments, such as improving the production of extracellular matrix.

With the presentation, the professionals were able to learn firsthand about the benefits of this new treatment, which was received with great interest by those present.